CIK 0001509261 · Non-accelerated filer<br>Smaller reporting company
Rezolute, Inc.
Sign in to watch- Ticker
- RZLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 273440894
- Phone
- 650-206-4507
- Business address
- 275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
- Former names
- AntriaBio, Inc., FITS MY STYLE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-28 | ROBERTS BRIAN KENNETH Chief Medical Officer | Purchase | +500 | $2.55 | $1K | 1,076 |
| 2024-03-15 | Evans Daron CFO | Purchase | +20,000 | $1.69 | $34K | 20,000 |
| 2024-03-14 | ROBERTS BRIAN KENNETH Chief Medical Officer | Purchase | +10,000 | $1.88 | $19K | 10,000 |
| 2024-03-08 | Evans Daron CFO | Purchase | +50,000 | $1.93 | $96K | 120,900 |
| 2024-03-07 | ROBERTS BRIAN KENNETH Chief Medical Officer | Purchase | +500 | $1.85 | $925 | 576 |
| 2024-03-07 | Kim Young-Jin Director | Purchase | +36,503 | $1.91 | $70K | 115,450 |
| 2024-03-07 | ROBERTS BRIAN KENNETH Chief Medical Officer | Purchase | +500 | $1.85 | $925 | 500 |
| 2024-02-26 | Elam Nevan C CEO | Purchase | +5,000 | $1.68 | $8K | 7,817 |
| 2024-02-26 | ROBERTS BRIAN KENNETH Chief Medical Officer | Purchase | +2,000 | $1.70 | $3K | 42,552 |
| 2024-02-23 | ROBERTS BRIAN KENNETH Chief Medical Officer | Purchase | +6,000 | $1.69 | $10K | 40,552 |
| 2024-02-16 | ROBERTS BRIAN KENNETH Chief Medical Officer | Purchase | +7,000 | $1.31 | $9K | 34,552 |
| 2024-02-16 | Evans Daron CFO | Purchase | +41,900 | $1.30 | $54K | 70,900 |
| 2024-02-16 | Evans Daron CFO | Purchase | +4,500 | $1.37 | $6K | 4,500 |
| 2024-02-16 | Evans Daron CFO | Purchase | +4,500 | $1.37 | $6K | 4,500 |
| 2024-01-23 | Evans Daron CFO | Grant or award · Employee Stock Option (Right to Buy) | +275,000 | 275,000 | ||
| 2024-01-23 | ROBERTS BRIAN KENNETH Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2024-01-23 | Elam Nevan C CEO | Grant or award · Employee Stock Options (Right to Buy) | +340,000 | 340,000 | ||
| 2024-01-23 | Hogenhuis Wladimir Director | Grant or award · Director Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-01-23 | Labrucherie Gil M Director | Grant or award · Director Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-01-23 | FAUCHET PHILIPPE Director | Grant or award · Director Stock Option (Right to Buy) | +30,000 | 30,000 |
Page 6 of 14 · 279 trades